APA (7th ed.) Citation

Kajiwara, A., Saruwatari, J., Sakata, M., Morita, K., Kita, A., Oniki, K., . . . Nakagawa, K. (2013). Risk Factors for Adverse Symptoms During Dipeptidyl Peptidase-IV Inhibitor Therapy: A Questionnaire-Based Study Carried Out by the Japan Pharmaceutical Association Drug Event Monitoring Project in Kumamoto Prefecture. Drug Safety, 36(10), 981. https://doi.org/10.1007/s40264-013-0077-z

Chicago Style (17th ed.) Citation

Kajiwara, Ayami, et al. "Risk Factors for Adverse Symptoms During Dipeptidyl Peptidase-IV Inhibitor Therapy: A Questionnaire-Based Study Carried Out by the Japan Pharmaceutical Association Drug Event Monitoring Project in Kumamoto Prefecture." Drug Safety 36, no. 10 (2013): 981. https://doi.org/10.1007/s40264-013-0077-z.

MLA (9th ed.) Citation

Kajiwara, Ayami, et al. "Risk Factors for Adverse Symptoms During Dipeptidyl Peptidase-IV Inhibitor Therapy: A Questionnaire-Based Study Carried Out by the Japan Pharmaceutical Association Drug Event Monitoring Project in Kumamoto Prefecture." Drug Safety, vol. 36, no. 10, 2013, p. 981, https://doi.org/10.1007/s40264-013-0077-z.